SSgA SPDR ETFs Europe II plc SSgA SPDR MSCI Europe Health Care UCITS ETF (HLTH)
- Add to watchlist
- Create an alert
- This stock can be held in a
€218.95
n/a
€247.85
London
€218.95
n/a
€192.26
€763.91M
€0.70 (0.32%) Previous:
€0.70
n/a
n/a
EUR
ETP Basics
Issuer: | SSGA |
---|---|
Structure: | ETF |
Replication method: | Stocks - Full Replication |
Securities lending: | No |
Number of holdings: | 44 |
Size: | €763.9M |
Launch date: | 30 September 2001 |
Launch price: | €56.70 |
UCITS: | Yes |
Reporting status: | Yes |
Domicile: | Ireland |
Complex product: | Non-complex |
ISIN: | IE00BKWQ0H23 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
Index: | MSCI Europe Health Care 35/20 Capped Index |
---|---|
Aim: |
The investment objective of the tracker is to replicate the performance of the MSCI...
Read full aim for SSgA SPDR ETFs Europe II plc |
Leverage: | 100% |
Currency hedging: | No |
COSTS
Ongoing Charge (OCF/TER): | 0.18% |
---|---|
Management fee: | 0.18% |
Indicative spread: | 0.07% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
1 week 1W | 0.07% | 1 year 1Y | 12.82% |
---|---|---|---|
1 month 1M | 5.7% | 2 years 2Y | 19.16% |
3 months 3M | 8.01% | 3 years 3Y | 14.39% |
6 months 6M | 2.86% | 5 years 5Y | 43.67% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Security | Weight |
---|---|
NOVO NORDISK A/S | 20.53% |
ASTRAZENECA | 13.04% |
NOVARTIS AG | 12.29% |
ROCHE HOLDING AG | 12.20% |
SANOFI | 7.08% |
GSK | 4.57% |
ESSILORLUXOTTICA | 3.82% |
ALCON AG | 2.70% |
LONZA GROUP AG | 2.48% |
BAYER AKTIENGESELLSCHAFT | 1.80% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.